B&W Tek and LabWare Announce Strategic Partnership
News Mar 11, 2014
B&W Tek and LabWare have joined together to distribute a pre-configured Raman spectroscopy template solution that allows for seamless and easy automation of data acquisition from B&W Tek’s NanoRam handheld Raman spectrometer into LabWare’s Enterprise Laboratory Platform, allowing customers to reduce traditional cost and time associated with the implementation of Raman analytical technology.
LabWare’s Enterprise Laboratory Platform combines the award-winning LabWare LIMS™ and LabWare ELN™, a comprehensive and fully integrated Electronic Laboratory Notebook application, which enables companies to optimize compliance, improve quality, increase productivity and reduce costs. The preconfigured template solution leverages LabWare’s LabStation instrument integration engine to securely parse and map data generated by the NanoRam into the corresponding LabWare sample record. The Raman spectroscopy template solution is fully 21 CFR compliant, providing the framework for immediate benefits and flexibility to be configured to suit individual needs.
“It was our goal to expedite the way companies and individuals inspect their incoming raw materials and finished products,” says Jack Zhou, COO of B&W Tek, Inc. “To do so, we sought out LabWare Inc.’s expertise in laboratory automation and reporting to provide a process in which our NanoRam can help our customers reduce non-value added work and focus on increasing productivity. Together with LabWare’s automation framework and the NanoRam’s wireless capabilities, we have given our customers the opportunity to cut the cord and deliver real time results remotely in a secure, modern way.”
HIV-1 replicates in ninja-like ways. The virus slips through the membrane of vital white blood cells. Inside, HIV-1 copies its genes and scavenges parts to build a protective bubble for its copies. Now, supercomputers have helped model a key building block in the HIV-1 protective capsid, which could lead to strategies for potential therapeutic intervention in HIV-1 replication.READ MORE